Early and marked benefit with GPi DBS for Lubag syndrome presenting with rapidly progressive life-threatening dystonia

Mov Disord. 2009 Aug 15;24(11):1710-2. doi: 10.1002/mds.22656.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Blepharospasm / drug therapy
  • Blepharospasm / etiology
  • Botulinum Toxins, Type A / therapeutic use
  • Deep Brain Stimulation*
  • Disease Progression
  • Genes, Recessive
  • Genetic Diseases, X-Linked / genetics
  • Genetic Diseases, X-Linked / physiopathology
  • Genetic Diseases, X-Linked / therapy*
  • Globus Pallidus / physiopathology*
  • Histone Acetyltransferases
  • Humans
  • Magnetic Resonance Imaging
  • Male
  • Mutation, Missense
  • Parkinsonian Disorders / genetics
  • Parkinsonian Disorders / physiopathology
  • Parkinsonian Disorders / therapy*
  • Severity of Illness Index
  • TATA-Binding Protein Associated Factors / genetics*
  • Transcription Factor TFIID / genetics*

Substances

  • TATA-Binding Protein Associated Factors
  • Transcription Factor TFIID
  • Histone Acetyltransferases
  • TATA-binding protein associated factor 250 kDa
  • Botulinum Toxins, Type A